Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychosis, Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03730857
What this trial is testing

Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Calo Psychiatric Center 111
Post-approval studies (Phase 4)Study completedNCT00859872
What this trial is testing

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Who this might be right for
Schizophrenia
Central South University 198
Post-approval studies (Phase 4)Study completedNCT00893256
What this trial is testing

Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms
National Institute of Mental Health and Neuro Sciences, India 48
Large-scale testing (Phase 3)Study completedNCT04092686
What this trial is testing

A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 464
Early research (Phase 1)Study completedNCT04010305
What this trial is testing

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Who this might be right for
AgitationSchizophrenia
BioXcel Therapeutics Inc 135
Very early researchStudy completedNCT00708994
What this trial is testing

Cannabinoids, Neural Synchrony, and Information Processing

Who this might be right for
CannabisPsychotic Disorders
Yale University 42
Not applicableLooking for participantsNCT07056894
What this trial is testing

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

Who this might be right for
PsychosisAlcohol Use DisorderCannabis Use Disorder
Nova Scotia Health Authority 50
Not applicableStudy completedNCT06791122
What this trial is testing

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 262
Not applicableStudy completedNCT05127837
What this trial is testing

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Who this might be right for
PsychosisSchizophreniaSchizo Affective Disorder+2 more
University of Washington 601
Not applicableNot Yet RecruitingNCT07108673
What this trial is testing

Value of Voxel-Based Morphometry in Schizophrenia

Who this might be right for
Schizophrenia
Assiut University 96
Testing effectiveness (Phase 2)WithdrawnNCT01905605
What this trial is testing

Phosphatidylcholine Supplementation in Infants

Who this might be right for
SchizophreniaDiminished P50 Sensory Gating
University of Colorado, Denver
Not applicableStudy completedNCT00538629
What this trial is testing

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 471
Not applicableUnknownNCT01357005
What this trial is testing

Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan

Who this might be right for
Schizophrenia
Far Eastern Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00770744
What this trial is testing

Efficacy of Lu 31-130 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 93
Not applicableStudy completedNCT03286595
What this trial is testing

Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings

Who this might be right for
PsychosisClinical High Risk for Psychosis
University of California, Davis 60
Not applicableWithdrawnNCT03758495
What this trial is testing

Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression

Who this might be right for
SchizophreniaDepressive Disorder, Major
VA Office of Research and Development
Large-scale testing (Phase 3)Study completedNCT00249119
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
Janssen, LP 1,579
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Not applicableStudy completedNCT02498236
What this trial is testing

Target Engagement for Oxytocin: Dose Ranging Study

Who this might be right for
Schizophrenia Spectrum
University of California, Los Angeles 51
Not applicableStudy completedNCT07437365
What this trial is testing

Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia

Who this might be right for
Schizophenia Disorder
Psychiatric Hospital of the Cross 90
Next Page